SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The revenue for the March 2025 quarter is pegged at Rs. 6229.60 millions, about 11.34% up against Rs. 5595.30 millions recorded during the year-ago period.Profit for the quarter ended March 2025 rises by 70.12% to Rs. 614.80  millions from Rs. 361.40 millions.The company reported a good operating profit of 903.70 millions compared to 701.70 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 6229.60 5595.30 11.34 21736.50 22669.10 -4.11 21736.50 22669.10 -4.11
Other Income 17.10 11.10 54.05 135.80 41.80 224.88 135.80 41.80 224.88
PBIDT 903.70 701.70 28.79 2762.30 2703.10 2.19 2762.30 2703.10 2.19
Interest 74.80 80.90 -7.54 296.80 301.60 -1.59 296.80 301.60 -1.59
PBDT 828.90 620.80 33.52 2465.50 2401.50 2.67 2465.50 2401.50 2.67
Depreciation 122.10 123.40 -1.05 477.90 476.70 0.25 477.90 476.70 0.25
PBT 706.80 497.40 42.10 1987.60 1924.80 3.26 1987.60 1924.80 3.26
TAX 92.00 136.00 -32.35 414.50 506.00 -18.08 414.50 506.00 -18.08
Deferred Tax -5.00 -15.00 -66.67 35.00 10.00 250.00 35.00 10.00 250.00
PAT 614.80 361.40 70.12 1573.10 1418.80 10.88 1573.10 1418.80 10.88
Equity 912.70 919.40 -0.73 912.70 919.40 -0.73 912.70 919.40 -0.73
PBIDTM(%) 14.51 12.54 15.67 12.71 11.92 6.57 12.71 11.92 6.57

Aarti Drugs Share Price

384.00 -4.45 (-1.15%)
11-May-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1872.40
Dr. Reddys Lab 1282.15
Cipla 1304.70
Zydus Lifesciences 956.65
Lupin 2249.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×